Valuation: GI Dynamics, Inc.

Market Cap 440K 387K 366K 332K 624K 42.28M 628K 4.39M 1.69M 21.58M 1.65M 1.62M 69.33M P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 3.28M 2.88M 2.73M 2.47M 4.65M 315M 4.67M 32.66M 12.61M 161M 12.31M 12.05M 516M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 05/08/2025
Director of Finance/CFO 57 01/08/2025
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 20/10/2020
Director/Board Member - -
Director/Board Member 69 01/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/1/21 Free

Chairman

1,384,483 0.4875%
28/1/21 Free

Chief Executive Officer

11,075,869 3.8998%

Financials

2019 2020
Net sales - -
Net income -17.33M -15.24M -14.42M -13.07M -24.56M -1.66B -24.7M -173M -66.66M -849M -65.08M -63.67M -2.73B -11.14M -9.79M -9.26M -8.4M -15.78M -1.07B -15.87M -111M -42.83M -545M -41.81M -40.9M -1.75B
Net Debt 2.89M 2.54M 2.4M 2.18M 4.09M 277M 4.11M 28.75M 11.1M 141M 10.84M 10.6M 454M 2.84M 2.5M 2.36M 2.14M 4.02M 273M 4.05M 28.27M 10.92M 139M 10.66M 10.43M 447M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock